Woman’s Inoperable Brain Tumor Shrinks In Just Five Days Thanks To Cancer Breakthrough
In March 2024, doctors at Mass General Brigham tested a bold variation of CAR‑T therapy on three people with recurrent glioblastoma, one of the deadliest brain cancers known. Instead of relying on standard protocols, they combined an existing CAR‑T approach with targeted antibodies, effectively sharpening the immune system’s aim inside the brain. The treatment was delivered directly into the fluid surrounding the brain and spinal cord, bringing engineered immune cells face‑to‑face with the tumor. The response stunned them. One patient’s…